Meet Our Team
About Us
Magnolia Market Access provides tailored strategies and insights to pharmaceutical companies, device manufacturers, and trade associations meeting their market access, HEOR, and healthcare policy needs. Our experts provide 360-degree perspectives and analysis of our in-house and client specific clinical and real-world data to shape policy, communicate value, secure reimbursement, and drive patient access. Magnolia Market Access works with you to maximize access from the earliest stages of development through patent expiration and beyond.
Amanda Forys
Managing Partner, Magnolia Market Access
[email protected]
Amanda Forys is Managing Partner at Magnolia Market Access. Her consulting and manufacturer experience has covered a wide range of commercialization topics, including health policy, pricing and rebating, coding, coverage and reimbursement, health economics, budget impact modeling, patient assistance design, and training for specialty pharmaceuticals, biosimilars, organ transplantation, and devices.
Market Access
-
Amanda O’Hora
SVP, Reimbursement & Market Access
[email protected]
Amanda O’Hora, is Senior Vice President of Reimbursement & Market Access at Magnolia Market Access. She has more than 24 years’ experience conceptualizing and implementing a broad range of commercialization activities for manufacturers of drugs, biologicals, cell and gene therapies, devices, diagnostics, and digital therapeutics. In addition to life science manufacturers, she also supports trade associations, health plans, and health systems.
Payer Strategy & Commercialization
-
Ajay Keshava
SVP, Commercialization Strategy
[email protected]
Ajay Keshava is Senior Vice President of Commercialization Strategy at Magnolia Market Access. Ajay has over 20 years of experience both in industry and management consulting, in which he has covered all aspects of cross-functional development, approval and launch of drug, device and combination products, business development and acquisitions, interactions with regulators, as well as organizational design and scale up for both pharma and device companies.
Real-World Evidence & HEOR Strategy
-
Pamela Landsman-Blumberg
SVP, Real-World Evidence & HEOR Strategy
[email protected]
Pamela Landsman-Blumberg is Senior Vice President of Real-World Evidence & HEOR Strategy at Magnolia Market Access. Pam is an industry-recognized subject matter expert in RWD evaluation and RWE generation. Her work designing and conducting outcomes research studies and implementing related strategies across the product lifecycle has improved the evidence- and value-based decision-making of industry investors, C-suite members, payers, providers, and patients.
Market Access & Analytics
-
Herman Chen
SVP, Market Access & Analytics
[email protected]
Herman Chen is Senior Vice President of Market Access & Analytics at Magnolia Market Access. He has over 20 years of healthcare consulting experience, collaborating directly with key stakeholders across the US healthcare system, including pharmaceutical manufacturers, hospitals and providers, private payers, managed care organizations, and pharmacy benefit managers.
Client Services
-
Sean McGonigal
Vice President, Growth
[email protected]
Sean McGonigal is Vice President, Growth, at Magnolia Market Access. Sean has almost a decade of experience in the pharmaceutical commercialization space, covering topics such as market access, market research, marketing and advertising, medical communications, and healthcare technology. In his current role, Sean is responsible for identifying opportunities where Magnolia’s tailored strategies and solutions could help clients maximize access from the earliest stages of development through patent expiration and beyond.